Galderma stock faces CFO transition before December vote
Published on 11/06/2026 at 12:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGovernance Changes Set December Vote
- Luigi La Corte will leave Galderma after a transition period, with succession details still pending.
- Shareholders will vote on two board candidates and a larger board at the December meeting.
- The proposed changes are aimed at strengthening governance as Galderma pursues its dermatology growth strategy.
Galderma announced on Monday, November 2, 2026, that Chief Financial Officer Luigi La Corte will leave the company to pursue a significant new opportunity. The announcement was included in a Galderma press release covering proposed board appointments and a planned extraordinary general meeting.
La Corte will remain CFO during the transition period to support business continuity and a smooth handover. Galderma said it will provide further details on the succession arrangements and the transition timetable in due course. No successor was named in the announcement.
Board Proposals Go To Shareholders
The board has proposed Rosalind Brewer and Petra Rumpf as new directors. Brewer is also proposed for individual election to the Compensation Committee. The company said both candidates bring leadership and governance experience across consumer-facing businesses, healthcare, medtech and life sciences.
The virtual extraordinary general meeting is scheduled for December 3, 2026, at 14:00 CET. Shareholders are expected to vote on the two appointments and on raising the board's maximum size from 10 to 11 members. Sherilyn McCoy is set to step down after seven years because of conflicting obligations. If elected, Brewer and Rumpf would serve until the close of the next Annual General Meeting.
Chief Executive Officer Flemming Ornskov said the company remains focused on executing its Integrated Dermatology Strategy and delivering against its priorities. He also pointed to Galderma's recent inclusion in the Swiss Market Index as part of the company's recent momentum.
Galderma stock traded at 207.00 euros on Lang & Schwarz at 12:35 CET on Friday, November 6, 2026. Investors can follow the real-time quote of Galderma stock. The CFO succession process and the December shareholder vote are the next company-specific governance milestones.
Galderma Group AG
- Company: Galderma Group AG
- ISIN: CH1335392721
- Ticker: GALD
- Home exchange: SIX Swiss Exchange
- Lang & Schwarz quote: 207.00 euros at 12:35 CET on November 6, 2026
- Next event: Virtual extraordinary general meeting on December 3, 2026, at 14:00 CET
The Swiss market backdrop can be followed through current SMI market reports.
